AMI BHATTACHARYA: Open Payments
NPI 1881879393 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,459 in 131 payments from 20 companies in 2025. Trend: 2023 $2,202 · 2024 $2,450 · 2025 $2,459
Food & beverage: $2,380Education: $79
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $440 |
| Arcutis Biotherapeutics, Inc. | 12 | $303 |
| Galderma Laboratories, L.P. | 11 | $230 |
| E.R. Squibb & Sons, L.L.C. | 4 | $217 |
| Janssen Biotech, Inc. | 12 | $199 |
| Lilly USA, LLC | 4 | $183 |
| Incyte Corporation | 10 | $179 |
| Regeneron Healthcare Solutions, Inc. | 10 | $143 |
| Organon LLC | 4 | $113 |
| MAYNE PHARMA COMMERCIAL LLC | 16 | $98 |
Products named: Zoryve, SKYRIZI, NEMLUVIO, Sotyktu, TREMFYA, DUPIXENT, OPZELURA, RINVOQ.
Industry payments across TX — which companies pay providers there.
